Drug Trial Radar · NCT01537471
The Effects of Antihistamines on Pre-Pulse Inhibition
Last checked: Nov 20, 2026Latest source record: Jan 16, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
117
Actual
Start
Jan 2012
Primary completion
Sep 2012
Study completion Sep 2012
Sponsor
- Lead sponsor
- Duke UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Wallace H. Coulter Foundation
- First posted
- Feb 23, 2012
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Single group
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the investigators research is to test whether problems people have with processing their senses (feeling overwhelmed, distracted or upset by sounds and other stimuli) can be lessened by meclizine, a drug found in many over the counter antihistamines, which are medicines used for things like allergies, sleep problems, or the common cold.
Conditions
- Healthy
Interventions
PlaceboDrug
Placebo
MeclizineDrug
Meclizine 12.5 mg
MeclizineDrug
Meclizine 25 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in PPITime frame: Screening Day 1, Days 2-4
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Duke University Medical Center
Durham, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.